Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis. (Q53655424)

From Wikidata
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
scientific article published in October 2005
Language Label Description Also known as
English
Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis.
scientific article published in October 2005

    Statements

    title
    Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis. (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    16193895
    retrieved
    16 May 2018
    reference URL
    http://europepmc.org/abstract/MED/16193895
    author name string
    cites work

    Identifiers

     
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q53655424&oldid=1335651909"